Clinical Trials

780 enrolled

Lymphoid

Lymphoma, Follicular, Lymphoma, B-Cell, Marginal Zone

NCT05363319 2026-04-22

CEMI-LUNG

500 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05365581 2026-04-22

A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer

398 enrolled

Tumor-Agnostic

Adenocarcinoma

NCT05455619 2026-04-22

Amelia-1

52 enrolled

Breast Neoplasms, Hyperglycemia, Hyperinsulinism, Insulin Resistance

NCT05683418 2026-04-22

A Study to Evaluate the Safety and Tolerability of TOS-358 in Women With HR+ HER2- Breast Cancer

241 enrolled

Breast Neoplasms, Hereditary Sensory and Autonomic Neuropathies

NCT05948943 2026-04-22

EPIK-L1

Phase 2/3 Recruiting

232 enrolled

Lymphangioma, Lymphangioma, Cystic, Lymphatic Abnormalities

NCT06077760 2026-04-22

INTerpath-002

868 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06257264 2026-04-22

A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors

BreastGastrointestinalGenitourinaryGynecologicThoracic

258 enrolled

Urinary Bladder Neoplasms, Breast Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Endometrial Neoplasms, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

NCT06463587 2026-04-22

Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)

264 enrolled

Myasthenia Gravis

NCT06512350 2026-04-22

Identifying Patterns in the Breath of Individuals With Breast Cancer

5,175 enrolled

Breast Neoplasms

NCT06514794 2026-04-22

A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)

125 enrolled

Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT06525220 2026-04-22

A Phase 3 Study to Evaluate Petosemtamab Plus Pembrolizumab vs Pembrolizumab in First-line Treatment of Head and Neck Cancer (LiGeR - HN1)

700 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Laryngeal Diseases

NCT06585410 2026-04-22

Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma

369 enrolled

Dermatologic

Skin Neoplasms

NCT06624644 2026-04-22

A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma

Phase 2/3 Recruiting

135 enrolled

Dermatologic

Melanoma

NCT06625593 2026-04-22

A First-in-Human (FIH) Study of BG-C137, an Anti-Fibroblast Growth Factor Receptor 2b (FGFR2b) Antibody Drug Conjugate, in Participants With Advanced Solid Tumors

168 enrolled

Advanced Solid Tumor

NCT06679101 2026-04-22

DREAMM-10

520 enrolled

Plasma cell

Multiple Myeloma

NCT06769152 2026-04-22

A Phase II Clinical Study to Evaluate the Efficacy and Safety of HLX43 (Anti-PD-L1 ADC) in Patients With Advanced Gynecological Malignant Tumors

190 enrolled

Gynecologic

Uterine Cervical Neoplasms, Ovarian Neoplasms

NCT06785636 2026-04-22

P300

252 enrolled

Genitourinary

Genital Neoplasms, Male, Neoplasms, Neoplasms by Site, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms, Male Urogenital Diseases

NCT06805305 2026-04-22

DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)

180 enrolled

CNS

Glioblastoma

NCT06840886 2026-04-22

A Study of PHST001 in Advanced Solid Tumors

CNSGastrointestinalGynecologic

272 enrolled

Ovarian Neoplasms, Central Nervous System Neoplasms, Endometrial Neoplasms, Cholangiocarcinoma

NCT06846671 2026-04-22

CaDAnCe-302

250 enrolled

Leukemia, Lymphocytic, Chronic, B-Cell

NCT06898450 2026-04-22

A Study to Assess the Safety, Tolerability, and Efficacy of NDI-219216 in Patients With Advanced Solid Tumors.

134 enrolled

Werner Syndrome, Microsatellite Instability

NCT06922591 2026-04-22

Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients

183 enrolled

Lung Neoplasms

NCT06970743 2026-04-22

CaDAnCe-303

150 enrolled

Leukemia, Lymphocytic, Chronic, B-Cell

NCT06973187 2026-04-22

A Study to Evaluate the Safety and Efficacy of BGB-16673 Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

500 enrolled

Leukemia, Lymphocytic, Chronic, B-Cell

NCT07002034 2026-04-22

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

100 enrolled

Adjustment Disorders, Amyotrophic Lateral Sclerosis, Anxiety Disorders, Depression, Multiple Sclerosis, Neoplasms, Idiopathic Pulmonary Fibrosis

NCT07020221 2026-04-22

A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors

295 enrolled

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Gastrointestinal Neoplasms, Lung Neoplasms, Neoplasm Metastasis, Pancreatic Neoplasms, Colorectal Neoplasms

NCT07039916 2026-04-22

Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis

231 enrolled

Autoimmune Diseases, Myasthenia Gravis

NCT07085091 2026-04-22

A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors

GastrointestinalHead & NeckThoracic

170 enrolled

Squamous Cell Carcinoma of Head and Neck, Esophageal Squamous Cell Carcinoma, Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Head and Neck Neoplasms, Neoplasm Metastasis, Colorectal Neoplasms

NCT07099898 2026-04-22

A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC)

420 enrolled

Lung Neoplasms, Small Cell Lung Carcinoma

NCT07136779 2026-04-22

First-in-Human Trial of VBC101 in Participants With Advanced Solid Tumor Malignancies

310 enrolled

Participants With Advanced Solid Tumor Malignancies

NCT07144345 2026-04-22

Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Face and Scalp

DermatologicOther neoplasm

160 enrolled

Precancerous Conditions, Skin Diseases, Keratosis, Actinic

NCT07144852 2026-04-22

Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Upper Extremities

DermatologicOther neoplasm

260 enrolled

Precancerous Conditions, Skin Diseases, Keratosis, Actinic

NCT07169851 2026-04-22

A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer

204 enrolled

Nausea, Neoplasms, Vomiting, Drug-Related Side Effects and Adverse Reactions

NCT07211659 2026-04-22

OCTOPOD-IP

18 enrolled

Gynecologic

Ovarian Neoplasms

NCT07222267 2026-04-22

An Investigational Study of BG-75202 Alone and in Combination With Other Therapeutic Agents in Adults With Advanced Solid Tumors

86 enrolled

Breast Neoplasms

NCT07264959 2026-04-22

An Observational Study in Participants With Indolent Systemic Mastocytosis (ISM)

150 enrolled

Myeloid

Mastocytosis, Mastocytosis, Systemic

NCT07277231 2026-04-22

A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia

500 enrolled

Leukemia, Lymphocytic, Chronic, B-Cell

NCT07299747 2026-04-22

Clinical Trial of VBC103 in Patients With Advanced Malignant Solid Tumors

255 enrolled

Participants With Advanced Solid Tumor Malignancies

NCT07332455 2026-04-22

First-Time-in-Human Study of GSK5471713 in Adults With mCRPC

54 enrolled

Genitourinary

Prostatic Neoplasms

NCT07387068 2026-04-22

Trial to Evaluate the Safety and Preliminary Efficacy of GEN1079 in Participants With Advanced Solid Tumors

121 enrolled

Advanced Solid Tumors

NCT07404202 2026-04-22

Pan HER2

2,100 enrolled

Pan-tumor(NSCLC, GYN Cancers, BTC and UC)

NCT07412613 2026-04-22

Neoadjuvant/Adjuvant AK104 in Microsatellite Instability-high or Mismatch Repair-deficient, Resectable Colon Cancer

GastrointestinalOther solid neoplasm

386 enrolled

Resectable Colon Cancer

NCT07413757 2026-04-22

CHOICE

590 enrolled

Carcinoma, Non-Small-Cell Lung

NCT07450859 2026-04-22

A Study of Nuzefatide Pevedotin (BT5528) in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)

39 enrolled

Gastrointestinal

Neoplasm Metastasis, Pancreatic Neoplasms

NCT07521852 2026-04-22

A Phase IIa, Single-arm, Open-label Clinical Study to Evaluate the Efficacy, Safety and PK of CVM-1118 in Combination With Sintilimab and TACE in Participants With Incurable/Non-metastatic HCC